Fig. 5From: Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphomaImmunohistochemical analysis of MYC expression, proliferation, and survival of tumor cells. Spleen tumor samples were collected following a 5-day treatment (one cycle). Ki67 and cleaved caspase 3 (c-Casp3) staining were used to assess proliferation and survival of tumor cellsBack to article page